The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen. (Q45084307)
Jump to navigation
Jump to search
scientific article published in August 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen. |
scientific article published in August 2004 |
Statements
The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen (English)
Antonella Castagna
Nicola Gianotti
Laura Galli
Anna Danise
Enzo Boeri
Richard Hoetelmans
David Nauwelaers